AbbVie Newsroom

Morgan Stanley Adjusts Price Target on AbbVie to $196 From $191

MT Newswires50minutes ago

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Roche Holding AG (OtherRHHVF) and UnitedHealth (UNH)

TipRanks05:42 ET

Redburn Atlantic Adjusts Price Target on AbbVie to $203 From $207

MT NewswiresJul 10 10:05 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neurocrine (NBIX) and AbbVie (ABBV)

TipRanksJul 10 05:08 ET

AbbVie (ABBV) Gets a Buy From Barclays

TipRanksJul 10 05:00 ET

AbbVie Analyst Ratings

BenzingaJul 9 09:21 ET

AbbVie (ABBV) Receives a Buy From Cantor Fitzgerald

TipRanksJul 9 08:14 ET

AbbVie Analyst Ratings

BenzingaJul 2 13:24 ET

Buy Rating Affirmed for AbbVie on Strong Aesthetics Market Position and Positive Sales Outlook

TipRanksJul 1 21:28 ET

AbbVie Analyst Ratings

BenzingaJun 18 08:33 ET

AbbVie Analyst Ratings

BenzingaJun 5 06:17 ET

Strong Financial Outlook and Strategic Initiatives Underpin Buy Rating for AbbVie

TipRanksJun 2 21:17 ET

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Aerovate Therapeutics (AVTE)

TipRanksMay 22 05:55 ET

AbbVie Analyst Ratings

BenzingaMay 17 07:17 ET

Buy Rating Affirmed: AbbVie's Promising Growth Trajectory and Financial Outlook

TipRanksMay 14 07:01 ET

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

TipRanksMay 13 19:01 ET

Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190

MT NewswiresMay 8 08:35 ET

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Cytokinetics (CYTK)

TipRanksApr 30 03:15 ET

Hold Rating on AbbVie Amidst Humira Concerns and Biosimilar Competition Despite Strong Pipeline Prospects

TipRanksApr 30 02:11 ET

AbbVie Analyst Ratings

BenzingaApr 29 10:11 ET